The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning

Drowning is an acute respiratory failure as a result from immersion or submersion of the airways in a liquid medium (predominantly water). Inhalation of water causes severe lung damage due to the destruction of pulmonary surfactant, resulting in decreased lung elasticity, alveolar collapse, alterati...

Full description

Saved in:
Bibliographic Details
Main Authors: Mario Pezzi, Francesco Givigliano, Ottorino Perrone, Annamaria Scozzafava, Pietro Maglio, Patrizia Casella, Anna Maria Giglio, Mario Verre, Carlo Pietro Voci
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Critical Care
Online Access:http://dx.doi.org/10.1155/2020/9270791
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547145155084288
author Mario Pezzi
Francesco Givigliano
Ottorino Perrone
Annamaria Scozzafava
Pietro Maglio
Patrizia Casella
Anna Maria Giglio
Mario Verre
Carlo Pietro Voci
author_facet Mario Pezzi
Francesco Givigliano
Ottorino Perrone
Annamaria Scozzafava
Pietro Maglio
Patrizia Casella
Anna Maria Giglio
Mario Verre
Carlo Pietro Voci
author_sort Mario Pezzi
collection DOAJ
description Drowning is an acute respiratory failure as a result from immersion or submersion of the airways in a liquid medium (predominantly water). Inhalation of water causes severe lung damage due to the destruction of pulmonary surfactant, resulting in decreased lung elasticity, alveolar collapse, alteration of ventilation-perfusion ratio, intrapulmonary blood shunting, hypoxia, acute lung injury, and Acute Respiratory Distress Syndrome (ARDS). Poractant alfa (Curosurf®), a natural surfactant effective in the treatment of newborn respiratory distress, has been used in various forms of ARDS, but in drowning syndromes, experience is still poor. We describe a series of nine clinical cases of drowning, six adults and three children, treated in our Intensive Care Unit (ICU) with endobronchial administration of poractant alfa. After 24 and 48 hours of administration in all cases, there was an improvement in arterial blood gas analysis (ABG) parameters and imaging. All patients were discharged without clinical consequences.
format Article
id doaj-art-4d21ac5e43d44c45a0fd92992dfd24fc
institution Kabale University
issn 2090-6420
2090-6439
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Critical Care
spelling doaj-art-4d21ac5e43d44c45a0fd92992dfd24fc2025-02-03T06:45:49ZengWileyCase Reports in Critical Care2090-64202090-64392020-01-01202010.1155/2020/92707919270791The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by DrowningMario Pezzi0Francesco Givigliano1Ottorino Perrone2Annamaria Scozzafava3Pietro Maglio4Patrizia Casella5Anna Maria Giglio6Mario Verre7Carlo Pietro Voci8Anesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyAnesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyAnesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyAnesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyAnesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyAnesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyAnesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyAnesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyAnesthesia and Intensive Care Department, University Department of Thoracic Surgery General Hospital “Pugliese-Ciaccio”, Catanzaro, ItalyDrowning is an acute respiratory failure as a result from immersion or submersion of the airways in a liquid medium (predominantly water). Inhalation of water causes severe lung damage due to the destruction of pulmonary surfactant, resulting in decreased lung elasticity, alveolar collapse, alteration of ventilation-perfusion ratio, intrapulmonary blood shunting, hypoxia, acute lung injury, and Acute Respiratory Distress Syndrome (ARDS). Poractant alfa (Curosurf®), a natural surfactant effective in the treatment of newborn respiratory distress, has been used in various forms of ARDS, but in drowning syndromes, experience is still poor. We describe a series of nine clinical cases of drowning, six adults and three children, treated in our Intensive Care Unit (ICU) with endobronchial administration of poractant alfa. After 24 and 48 hours of administration in all cases, there was an improvement in arterial blood gas analysis (ABG) parameters and imaging. All patients were discharged without clinical consequences.http://dx.doi.org/10.1155/2020/9270791
spellingShingle Mario Pezzi
Francesco Givigliano
Ottorino Perrone
Annamaria Scozzafava
Pietro Maglio
Patrizia Casella
Anna Maria Giglio
Mario Verre
Carlo Pietro Voci
The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
Case Reports in Critical Care
title The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
title_full The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
title_fullStr The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
title_full_unstemmed The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
title_short The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
title_sort use of exogenous lung surfactant poractant alfa in acute respiratory failure by drowning
url http://dx.doi.org/10.1155/2020/9270791
work_keys_str_mv AT mariopezzi theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT francescogivigliano theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT ottorinoperrone theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT annamariascozzafava theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT pietromaglio theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT patriziacasella theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT annamariagiglio theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT marioverre theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT carlopietrovoci theuseofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT mariopezzi useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT francescogivigliano useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT ottorinoperrone useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT annamariascozzafava useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT pietromaglio useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT patriziacasella useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT annamariagiglio useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT marioverre useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning
AT carlopietrovoci useofexogenouslungsurfactantporactantalfainacuterespiratoryfailurebydrowning